NIH #R01CA194321
Imaging drug uptake and distribution in chemoradiation therapy of pancreatic cancer
- Amount
- $600K–$700K
- Period
- 2016-07-01 → 2022-06-30
- PIs
- 4
Awarded at SLOAN-KETTERING INST CAN RESEARCH
Kenneth H. Yu
Full Professor(heuristic)
Pancreatic and Hepatic Oncology Research · Oncology
Compare more Oncology professors.
h-index46
i10-index115
Publications422
Citations15,048
Grants
4 total · 0 active
NIH #R01CA208401
Protein and proteolytic activity biomarkers of early stage pancreatic cancer
- Amount
- $600K–$700K
- Period
- 2017-03-03 → 2022-02-28
- PIs
- 2
Awarded at SLOAN-KETTERING INST CAN RESEARCH
NIH #R01CA202762
Pharmacogenomic and circulating tumor cell approach to individualized treatment of pancreatic cancer
- Amount
- $500K–$600K
- Period
- 2016-08-01 → 2021-07-31
- PIs
- 2
Awarded at SLOAN-KETTERING INST CAN RESEARCH
Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →
Recent Public Signals
- New paper: Healthcare resource utilization and economic burden of metastatic pancreatic cancer: a US commercial and Medicare claims analysis (Figshare)2026-07-01
- New preprint: Pembrolizumab and Olaparib (POLAR) Maintenance Therapy in Metastatic Pancreatic Cancer With or Without Homologous Repair Deficiency: A Biomarker Selected Phase II Trial2025-09-01
Are you this professor?
No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.
Data Freshness
- Publications as of 2026-07-09
- Grants as of 2026-08-26
Data may not be current
Find elsewhere
ORCID: 0000-0002-4774-2672